Tel. : 01 45 33 67 17 / E-mail : coger@coger.fr
 Coger: Distributeur de reactifs de laboratoire
		
					Coger: Distributeur de reactifs de laboratoire			
        	 
            AVANTI POLAR LIPIDS , CYGNUS , LARODAN , ADIPOGEN , MYBIOSOURCE , SERVA NORDMARK, BIOWORLD, EDGEBIO , PANREAC APPLICHEM
| 
                            Ajouter au panier
                            
                         Le produit a été ajouté au panier Le stock est insuffisant. unités ont été rajoutées au panier Total:  | 
| 
                            Stock épuisé.
                            
                         
                            En rupture de stock
                         | 
| 
                            Quantité minimum d'achat
                            
                         
                            La quantité minimum d'achat n'est pas atteinte
                         | 
 
    
	  
	
	
    
    photos non contractuelles
Product description: Monoclonal Antibody. Antibody ANC244.8 binds to recombinant CD244-muIg (#ANC-544-020) in EIA, and to cell surface CD244 on human PBL in FACS. ANC244.8 binds to a CD244 epitope that is distinct from the binding sites of clone ANC2B4/3B12 (#ANC-259-020). It blocks binding of clone C1.7. Isotype: Mouse IgG1kappa. Immunogen: Recombinant soluble human CD244. Applications: ELISA, FACS. 50mM Sodium Phosphate pH 7.5, 100mM KCl, 150mM NaCl. CD244 (2B4; SLAMF4) is a 66kDa member of the CD2/SLAM related receptor family (SRR). It is expressed on NK, T cell subsets, monocytes and eosinophils. It is expressed at high levels on leuikemia initiating cells, and plays a role in their proliferative potential. In mice there are two transcription variants, a long form and a short form of CD244 each of which have distinct signaling properties. In humans, only the long form is expressed. Decreased CD244 expression on monocytes of SLE patients correlated (negatively) with autoantibody titer. CD244 mediated function in immune response can vary greatly dependant on the context of its ligation.
| 
					Alerte
					
				 Veuillez saisir les champs obligatoires! |